Gansu Province Introduces Measures for Management of Pharmaceutical Personnel
The Gansu Medical Products Administration has issued a set of “Measures for the Management of...
Policy / Regulatory
Guangdong Pharmaceutical Association Expands Off-Label Drug Use Catalogue for 2024
The Guangdong Pharmaceutical Association (GDPA) has released the Off-label Drug Use Catalogue for the year...
NHSA Seeks Public Input on National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has unveiled the adjustment plan for the National Reimbursement...
WuXi AppTec and WuXi Bio Shares Rally as US Biosecure Act Excluded from Defense Bill
Shares of Chinese Contract Development and Manufacturing Organizations (CDMOs) WuXi AppTec (SHA: 603259) and WuXi...
China’s CDE Opens Consultation on 83rd Batch of Generic Chemical Reference Preparations
The Center for Drug Evaluation (CDE), a key regulatory body in China, is currently in...
China’s NMPA Unveils Three-Year Smart Supervision Plan for Blood Product Industry
China’s National Medical Products Administration (NMPA) has unveiled the “Three-Year Action Plan for Smart Supervision...
China’s NMPA Issues New Supervision Measures for Medical Device Clinical Trials Starting October 2024
The National Medical Products Administration (NMPA) has approved the “Measures for Supervision and Inspection of...
Four More Chinese Provinces Include ART in Medical Insurance Payment System
The provincial governments of Jiangxi, Shanghai, Qinghai, and Zhejiang have added assisted reproductive technology (ART)...
China Unveils Ambitious 2024 Medical Reforms with Increased Investment and Policy Reforms
The State Council has issued a notification outlining key medical system reforms for 2024, aiming...
Jiangsu Hengrui Pharmaceuticals Receives FDA Form 483 Following Inspection Discrepancies
The U.S. Food and Drug Administration (FDA) has issued a Form 483 to Jiangsu Hengrui...
China’s NHC Launches Health Literacy Plan to Shift Focus to Preventative Healthcare
China’s National Health Commission (NHC), in collaboration with two other bureaus, has unveiled the “All-Citizen...
China’s NHC Mandates Urban Hospitals to Aid County-Level Medical Institutions
The National Health Commission (NHC) has issued a notification aimed at further promoting the allocation...
China’s NHSA and MoF Plan Expansion of Long-term Care Insurance System Pilot Program
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
Shenzhen’s Draft Proposal for VBP Drug Procurement and Medical Insurance Fund Management Released
The Healthcare Security Administration (HSA) Bureau of the Shenzhen municipality has released a “Shenzhen Drug...
GenScript Shares Slide on US Congressional Request for FBI Investigation
Shares of GenScript Biotechnology Co., Ltd (HKG: 1548), a China-based Contract Development and Manufacturing Organization...
NMPA Announces Digitalization of Medical Device Regulatory Documents
The National Medical Products Administration (NMPA) has announced a transition to digitalize regulatory documentation for...
China’s NHSA Launches New Procedures for Drug Catalogue Attribution Identification
The National Healthcare Security Administration (NHSA) has issued the “Procedures for Identification of Drug and...
China Unveils Comprehensive Plan to Tackle Unhealthy Practices in Pharma and Healthcare
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA),...
Beijing Unveils Action Plan to Boost Pharmaceutical and Health Industry by 2026
The Beijing People’s Government has issued an “Action Plan” outlining measures and targets to “Accelerate...
China’s CDE Issues Draft Guidelines for Patient-Centric Rare Disease Drug R&D
The Center for Drug Evaluation (CDE) has issued a notification regarding the patient-centric rare disease...